Who owns the ATROZEMB trademark?

The ATROZEMB trademark is owned by Liptis Pharmaceuticals USA, Inc..

What class is the ATROZEMB trademark registered in?

The ATROZEMB trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for ATROZEMB?

The USPTO serial number for ATROZEMB is 86658366.

What is the registration number for ATROZEMB?

ATROZEMB is registered under USPTO registration number 5167095.

Sealvo

Home Search: ATROZEMBATROZEMB #86658366

Back

Updated Oct 7, 2026·41 searches this week

View on USPTO TSDR Find similar marks

ATR

USPTO Trademark Record

REGISTERED

ATROZEMB

SN 86658366·Reg 5167095·Filed Jun 10, 2015

Owner Liptis Pharmaceuticals USA, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

ATROZEMB (Serial No. 86658366), Registration No. 5167095, is a registered US trademark filed on Jun 10, 2015 by Liptis Pharmaceuticals USA, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

renewal 10y period: March 22, 2027166 days remaining

Mark Intelligence

ATROZEMB (Reg. #5167095) is a registered US trademark that has been protecting its owner, Liptis Pharmaceuticals USA, Inc., since 2015. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jun 10, 2015

SERIAL

86658366

REG#

5167095

REGISTERED

Mar 21, 2017

Filing Information

StatusREGISTERED

Filing DateJun 10, 2015

Serial Number86658366

Registration No.5167095

Registration DateMar 21, 2017

Status DateSep 21, 2023

Published for OppositionOct 27, 2015

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlySection 8 AcceptedSection 15 AcknowledgedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Aug 01, 2016

First use in commerce: Aug 01, 2016

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

25 events

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Mar 21, 2026

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Sep 21, 2023

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Sep 21, 2023

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Sep 21, 2023

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

TEAS SECTION 8 & 15 RECEIVED

Mar 21, 2023

TEAS SECTION 8 & 15 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Mar 21, 2022

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Mar 21, 2017

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Feb 15, 2017

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Feb 14, 2017

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

STATEMENT OF USE PROCESSING COMPLETE

Jan 23, 2017

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jan 17, 2017

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Dec 22, 2016

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Dec 22, 2016

USE AMENDMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 23, 2016

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jun 21, 2016

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Jun 21, 2016

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Jun 21, 2016

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Dec 22, 2015

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Oct 27, 2015

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 27, 2015

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 07, 2015

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 18, 2015

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Sep 17, 2015

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 15, 2015

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jun 13, 2015

NEW APPLICATION ENTERED

Other Marks by Liptis Pharmaceuticals USA, Inc.

Additional USPTO filings from the same owner.

GLY

GLYBOFEN

78253826

LIPTIS PHARMACEUTICALS USA, INC.

REGISTERED

PRO

PROSTALIS

90563160

Liptis Pharmaceuticals USA, Inc.

REGISTERED

DOR

DORMAREST

90563395

Liptis Pharmaceuticals USA, Inc.

REGISTERED

LPL

LP LIPTIS PHARMACEUTICALS

85763084

LIPTIS PHARMACEUTICALS USA, INC.

REGISTERED

Other Marks by Brian A. Bloom

Additional USPTO filings handled by the same attorney of record.

UNT

UNTANGLED

87606318

REGISTERED

86449854

REGISTERED

POW

POWERLESS

99473170

REGISTERED

LAU

LAUREN ROBERTS

99473163

REGISTERED

ATROZEMB

Run a conflict check

Other Marks by Liptis Pharmaceuticals USA, Inc.

Other Marks by Brian A. Bloom

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company